Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.RYZO TATAMI, R Takeda, Honin Kanaya et al.|Circulation|1981Cited by 250
Impact of combined lipid lowering with blood pressure control on coronary plaque regression: rationale and design of MILLION studyMasa‐aki Kawashiri, Masakazu Yamagishi, Kenji Sakata et al.|Heart and Vessels|2014Cited by 10
Impact of Severe Coronary Disease Associated or Not Associated with Diabetes Mellitus on Outcome of Interventional Treatment Using Stents: Results from HERZ (Heart Research Group of Kanazawa) AnalysesKatsuharu Uchiyama, Masakazu Yamagishi, Hidekazu Ino et al.|Journal of International Medical Research|2011Cited by 8
Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) studyMasakazu Yamagishi, Masa‐aki Kawashiri, Kenji Sakata et al.|Heart and Vessels|2016Cited by 7
Impact of lesion morphology and associated procedures for left main coronary stenting on angiographic outcome after intervention: sub-analysis of Heart Research Group of Kanazawa, HERZ, StudyMasa‐aki Kawashiri, Masakazu Yamagishi, Kenji Sakata et al.|Cardiovascular Intervention and Therapeutics|2013Cited by 5